YIH
ONEM

Y-Intercept (HK)’s 1Life Healthcare ONEM Stock Holding History

Y-Intercept (HK)’s Portfolio ONEM Stock Details ONEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-7,721
Closed -$292K – 970
2021
Q1 		$292K Sell
7,721
-5,065
-40% -$238K 0.08% 415
2020
Q4 		$556K Buy
+12,786
New +$437K 0.23% 124

Other funds holding ONEM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Tiger Global Management
Tiger Global Management New York $22.8B AUM 30.07% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Y-Intercept (HK)'s ONEM Position: Q2 2021 in Review

Y-Intercept (HK) sold out of 1Life Healthcare (ONEM) in Q2 2021, closing a stake of 7,721 shares — an estimated $292K sold.

Y-Intercept (HK) first reported a position in ONEM in Q4 2020 and held it in 2 quarters. The position peaked at $556K in Q4 2020. 220 funds tracked by Wall St. Rank hold ONEM as of Q2 2021.

  • Y-Intercept (HK) reported no remaining 1Life Healthcare position as of Q2 2021 after selling out during the quarter.
  • Y-Intercept (HK) sold 7,721 1Life Healthcare shares in Q2 2021, an estimated $292K.
  • Y-Intercept (HK) first reported a position in 1Life Healthcare in Q4 2020 and held it in 2 quarters.
  • Y-Intercept (HK)'s 1Life Healthcare position peaked at $556K in Q4 2020.
  • 220 funds tracked by Wall St. Rank held 1Life Healthcare as of Q2 2021.

Based on Y-Intercept (HK)'s 13F filing for Q2 2021, filed 12 Aug 2021.